• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Novo vs. KBP: How a $1.3B deal turned into an international legal fight
gold coins and bars
Biotech

Takeda strikes Innovent pact worth up to $11.4B

The deal, which includes $10.2 billion in milestones, puts the biologics at the center of Takeda’s efforts to establish new growth drivers.
Nick Paul Taylor Oct 22, 2025 9:15am
Bringing clinical trials to the community a new model for precision enrollment
Sponsored

Bringing clinical trials to the community: a new model for precision enrollment

Oct 20, 2025 8:00am
On target clinical trial success bullseye score

Sanofi's $1.7B bet beats CSL's Zemaira in phase 2 face-off

Oct 22, 2025 10:35am
Redefining Biotech How AI and Real-World Data Power Patient-Centered Progress
Sponsored

Redefining Biotech: AI, RWD, and Patient-Centered Progress

Oct 20, 2025 8:00am
brain

Alector halves staff after GSK-partnered antibody fails in ph. 3

Oct 22, 2025 11:23am
Launch

Psychiatrist launches new CRO with patient-centered focus

Oct 22, 2025 2:22pm
More News

Arcturus’ stock halves on cystic fibrosis readout

Oct 22, 2025 1:01pm
Fierce Healthcare

Government shutdown updates: CMS lifts PFS claims hold

Oct 22, 2025 11:30am

Ipsen inks €1B buyout of French biotech ImCheck

Oct 22, 2025 10:33am

Fierce Biotech Layoff Tracker 2025: Alector, Galapagos & more

Oct 22, 2025 9:00am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings